Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Flomics logo — Liquid biopsies with cell-free RNA. A revolutionary tool for...

Flomics

Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification.

Founded 2018 Spain Spain 26 employees Seed Total: $1.00M Biotechnology, Health Care

General Information

Company Name Flomics
Founded Year 2018
Location Spain Spain +1
Employees 26
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when Flomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Flomics

Flomics Biotech is a biotechnology startup based in Spain that is focused on developing innovative blood-based diagnostic tools for a wide range of complex diseases. The company's slogan - "Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification." - emphasizes its commitment to revolutionizing the diagnostic landscape. Founded in 2018, Flomics leverages proprietary technology to accurately identify pattern changes in the circulating long RNA molecules of patients. These changes are then utilized to identify RNA alterations associated with disease states using deep learning algorithms, offering a faster, more cost-effective, and non-invasive approach to diagnosis and prognosis. Flomics Biotech recently secured a €1.00M Seed Round investment on 28 March 2022, signifying investor confidence in its disruptive approach to disease diagnosis and patient stratification. While the specific investors behind this recent investment are not disclosed, this funding round is indicative of the potential that Flomics Biotech holds in the biotechnology and healthcare industries. With its compelling value proposition and focus on leveraging cutting-edge technology for impactful healthcare solutions, Flomics Biotech emerges as an intriguing player in the biotech startup ecosystem.

Taxonomy: liquid biopsy, disease detection, bioinformatics analysis, genomics facilities, biomedical technology, cloud platform, SaaS model, medical diagnostics, blood sample analysis

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 28 Mar 2022

Flomics Alternatives & Competitors

Flomics vs
RealSeq Biosciences
RealSeq Biosciences United States

Leaders in small RNA detection

Seed
16 employees
Biotechnology
Compare Flomics vs RealSeq Biosciences
Flomics vs
miRecule, Inc.
miRecule, Inc. United States

RNA Therapeutics

Seed
12 employees
Biopharma, Biotechnology
Compare Flomics vs miRecule, Inc.
Flomics vs
Helicos Biosciences Corporation
Helicos Biosciences Corporation United States

The Helicos® Genetic Analysis System is the first technology capable of true direct RNA, cDNA and DN...

Series A
8 employees
Biotechnology, Health Care
Compare Flomics vs Helicos Biosciences Corporation

FAQ About Flomics

Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification.
Flomics was founded in 2018.
Flomics is headquartered in Spain.
Flomics operates in the following industries: Biotechnology, Health Care.
Flomics has approximately 26 employees.
Flomics has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Top alternatives and competitors to Flomics include RealSeq Biosciences, miRecule, Inc., Helicos Biosciences Corporation, Exheus, Systems Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flomics and RealSeq Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Flomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy